4,026 lug 2016Carbylan therapeuticsEx dipendente, meno di un annoPalo Alto, CAConsigliaGradimento del CEOPronostico commercialeVantaggiGood benefits for it's size. Had good leadership with CEO.SvantaggiProduct was not so good, failed clinical trail.Mostra di più
5,020 nov 2017Dipendente anonimoEx dipendenteConsigliaGradimento del CEOPronostico commercialeVantaggigreat people, great technology, it was a very collaborative group that all worked well together. Everyone was excited by the technologySvantaggiWe ran into clinical difficulties in our phase 3 trial. I think some of the FDA requirements for combo products are very difficult to acheiveMostra di piùUtileCondividi
4,011 set 2013Dipendente anonimoEx dipendenteConsigliaGradimento del CEOPronostico commercialeVantaggigreat group of people, flexibility, ability to work independently.Svantaggilimited funding, not much growth potential to move around within the company. not many benefits.Mostra di piùUtileCondividi